USPTO Allows Antibody Genus Claims in Patent Enabled by Integral Molecular’s Paratope-PLUS™ CDR-Scanning
Data-Driven Technology Re-establishes a Pathway for Antibody Genus Claims that Meet US Patent Requirements Philadelphia – Integral Molecular, the industry leader in the discovery […]